The basic principle in the Biocidal Products Regulation ((EU) No 528/2012 (BPR)) is that a biocidal product (BP) must be authorised before it can be made available on the market or used in the European Union (EU)/ European Economic Area (EEA).
This takes place in two consecutive steps. As the first step, the active substance is evaluated and, provided the criteria are fulfilled, is then approved in a specified product-type (PT). The second step is the authorisation of each BP consisting of, containing or generating the approved active substance(s).
This document concerns the first step, approval of active substances.
October 2016
Collegati
| Descrizione | Lingua | Dimensioni | Downloads | |
|---|---|---|---|---|
 |
Abbonati Chemicals
|
EN | 5803 kB | 1 |
Regolamento (UE) 2018/605 della Commissione, del 19 aprile 2018, che modifica l'allegato II del regolamento (CE) n. 1107/2009 stabilendo criteri scientifici per la determinazi...
ID 7159 | Update 15.01.2020
Update 15.01.2020
UFI in etichetta
Regolamento delegato (UE) 2020/11 della Commissio...
ID 21936 | 27.05.2024
This Methodological Guidance clarifies some aspects of the voluntary application of the ‘safe and ...
Testata editoriale iscritta al n. 22/2024 del registro periodici della cancelleria del Tribunale di Perugia in data 19.11.2024